Digital Biomarkers Market- Europe Anticipated to Attain the Highest Growth Rate During 2019–2025
With the latest technological revolutions in the spheres of mobile and digitally connected technologies, the concept of biomarkers has diverged into a new class altogether called digital biomarkers. This new emerging concept of digital biomarkers has found implications in both clinical trials as well as clinical care. The technology enables the collection of consumers generated physiological and behavioral data with the help of digitally connected tools such as wearable, implantable, and ingestible devices and sensors.
The report by BIS Research, titled “Global Digital Biomarkers Market-Analysis and Forecast, 2019–2025”, tracks the particular market compiled in a bunch of 270 pages, including insightful figures and market tables. According to the study, the market is expected to grow at a double-digit CAGR of 40.39% during the forecast period 2019–2025. The growth is primarily due to the increasing number of synergistic associations among the industry stakeholders.
The research is carried out through extensive primary interviews (in-house experts, market players, and industry leaders) and secondary research (with the help of various paid and unpaid databases), together with the analytical tools that have been used to build the predictive models.
Explosion of Wearable Technology and Smartphones Pushing the Digital Biomarkers Market
The tremendous growth rate of the digital biomarkers market is facilitated by several factors, such as rapidly increasing uptake of smartphones, wearables, and the advent of high-speed networks and connectivity solutions. The use of wearables in clinical research has immense potential to convert longitudinal biometric data sets into meaningful and actionable intelligence that can be used as a digital therapeutic to treat medical conditions.
Digital Biomarkers Market, by Type, Globally (2018–2025)
There are two ways to classify digital biomarkers:
a) Systems and Tools for the Collection of Data
There is are a plethora of companies engaged in the collection of data with the help of means such as wearables, implantable sensors, mobile applications, and smart home devices. An example of a company in this space is AliveCor, which has developed DA-cleared single-lead EKG for $99.
(b) Systems for the Integration of Data
Apart from data collection companies, there are companies engaged in developing platforms that integrate sensor collected data. Apple Inc. has been investing in a data integration platform called ReasearchKit, which develops customized apps and products for an array of medical conditions.
Digital Biomarkers Market, by Application/Therapeutic Area, Globally (2018–2025)
In terms of the application of digital biomarkers, cardiovascular diseases hold the largest share of the overall market. During the forecast period, the pain management segment is expected to witness the highest CAGR of 59.07%, primarily due to the increasing development and adoption of AR/VR solutions for the detection and treatment of chronic pain. This is followed by the mood and behavior segment, the growth of which is majorly due to the rising number of mental health cases such as stress and depression.
Digital Biomarkers Market, by End Users — Globally (2018–2025)
In terms of end-users, biopharma companies led the global digital biomarkers market holding, an estimated market share of 57% in 2018. The health insurance payers are anticipated to emerge as the largest end-user group in the digital biomarkers market globally during the forecast period (2019–2025), primarily due to the increasing use of digital biomarkers by payer groups to effectively stratify patients to devise individualized care plans.
The Digital Biomarkers Market, by Region (2018–2025)
Asia-Pacific is currently the largest market in the digital biomarkers sphere, by region. This is due to the elevated level of smartphone and wearable technology in the region as well as the high incidence of diseases related to lifestyle that is pushing consumers in the region to monitor their conditions. However, Europe is expected to attain the highest CAGR of 41.99% during the forecast period. The growth is principally due to increase standardization and collaboration among key stakeholders in the industry.
Regulatory Aspects of Modular Components Associated with Digital Biomarkers
To boost the market entry of digital tools, the regulatory body FDA has launched a pre-certification program. With the help of this precertification program, companies can fast-track the release of their product and its updates. Major technology companies such as Apple, Fitbit, Samsung and Verily, and pharmaceutical companies such as Johnson & Johnson and Roche have significantly benefited from this pre-certification program.
Future Potential and Opportunities
The digital biomarkers market is currently at a very nascent stage and presents numerous challenges that require industry-wide collaboration to address. Some of the major challenges are the integration of data from various digital and non-digital sources in order to provide clinicians with mean